Ipsen to expand production of drugs at Dublin facility

The €27m investment will facilitate the increased production of medical treatments for niche cancers and rare diseases
The Ipsen facility in Dublin which will be upgraded in a €27m investment.

The Ipsen facility in Dublin which will be upgraded in a €27m investment.

Pharmaceutical firm Ipsen is to invest €27m to upgrade and expand its manufacturing facility in Blanchardstown in Dublin.

The investment will facilitate the increased production of medical treatments for niche cancers and rare diseases.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited